JAK inhibitor


Entry
DG02020                     DGroup                                 
Name
JAK inhibitor
Type
Target
Member
DG00719  
Ruxolitinib
 D09959  
Ruxolitinib (USAN/INN)
 D09960  
Ruxolitinib phosphate (JAN/USAN)  <JP/US>
DG02968  
Fedratinib
 D10630  
Fedratinib (USAN/INN)
 D11296  
Fedratinib hydrochloride (USAN)  <US>
D11768  
Pacritinib (USAN/INN)  <US>
DG00742  
Tofacitinib
 D09970  
Tofacitinib (USAN)
 D09783  
Tofacitinib citrate (JAN/USAN)  <JP/US>
D10308  
Baricitinib (JAN/USAN/INN)  <JP/US>
DG02829  
Upadacitinib
 D10994  
Upadacitinib (USAN/INN)  <US>
 D10995  
Upadacitinib tartrate (USAN)
 D11048  
Upadacitinib hydrate (JAN)  <JP>
DG01991  
Filgotinib
 D10871  
Filgotinib (USAN/INN)
 D10872  
Filgotinib hydrochloride (USAN)
 D11106  
Filgotinib maleate (JAN/USAN)  <JP>
DG02833  
Itacitinib
 D10944  
Itacitinib (USAN/INN)
 D10945  
Itacitinib adipate (JAN/USAN)
DG01853  
Peficitinib
 D10653  
Peficitinib (USAN/INN)
 D10721  
Peficitinib hydrobromide (JAN/USAN)  <JP>
D11400  
Abrocitinib (JAN/USAN)  <JP/US>
D11046  
Delgocitinib (JAN/USAN)  <JP>
DG01366  
Momelotinib
 D10315  
Momelotinib (USAN/INN)
 D10358  
Momelotinib dihydrochloride (USAN)
 D10889  
Momelotinib hydrochloride hydrate (JAN)
DG02005  
Oclacitinib
 D10141  
Oclacitinib (USAN)
 D10142  
Oclacitinib maleate (USAN)
DG03044  
Brepocitinib
 D11537  
Brepocitinib (USAN)
 D11538  
Brepocitinib tosylate (USAN)
DG03058  
Zotiraciclib
 D11599  
Zotiraciclib (USAN)
 D11600  
Zotiraciclib citrate (USAN)
DG03080  
Gusacitinib
 D11676  
Gusacitinib (USAN/INN)
 D11677  
Gusacitinib hydrochloride (USAN)
DG03114  
Deuruxolitinib
 D11866  
Deuruxolitinib (USAN)
 D11867  
Deuruxolitinib phosphate (USAN)
DG03175  
Ivarmacitinib
 D12211  
Ivarmacitinib (USAN)
 D12212  
Ivarmacitinib sulfate (USAN)
D10365  
Gandotinib (USAN)
D10585  
Decernotinib (USAN/INN)
D10728  
Solcitinib (USAN/INN)
D11970  
Ritlecitinib tosilate (JAN)
D12118  
Nezulcitinib (USAN)
 » expand
Class
Anti-inflammatory
 DG01985  Disease modifying anti-rheumatic drug (DMARD)